Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial

BACKGROUND: Staphylococcus aureus bacteremia is associated with significant morbidity and mortality. To treat this infection, the current standard of care includes intravenous anti-staphylococcal beta-lactam antibiotics and obtaining adequate source control. Combination therapy with an aminoglycosid...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Matthew P., Lawandi, Alexander, Butler-Laporte, Guillaume, Paquette, Katryn, Lee, Todd C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975696/
https://www.ncbi.nlm.nih.gov/pubmed/29843781
http://dx.doi.org/10.1186/s13063-018-2668-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975696/
https://www.ncbi.nlm.nih.gov/pubmed/29843781
http://dx.doi.org/10.1186/s13063-018-2668-6

Ejemplares similares